Dose-escalation study of SAR439859, an oral selective estrogen receptor degrader, in postmenopausal women with estrogen receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer Meeting Abstract

  

Authors:	Campone, M.; Bardia, A.; Ulaner, G. A.; Chandarlapaty, S.; Gosselin, A.; Doroumian, S.; Ming, J.; Celanovic, M.; Linden, H. M.
Abstract Title:	Dose-escalation study of SAR439859, an oral selective estrogen receptor degrader, in postmenopausal women with estrogen receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer
Meeting Title:	42nd Annual San Antonio Breast Cancer Symposium (SABCS)
Journal Title:	Cancer Research
Volume:	80
Issue:	4 Suppl.
Meeting Dates:	2019 Dec 10-14
Meeting Location:	San Antonio, TX
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2020-02-01
Language:	English
ACCESSION:	WOS:000527012502400
DOI:	10.1158/1538-7445.Sabcs19-p5-11-02
PROVIDER:	wos
Notes:	Meeting Abstract: P5-11-02 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/167943